CMG Pharmaceutical Co. Ltd (058820) — Working Capital to Net Assets Ratio
CMG Pharmaceutical Co. Ltd (058820) has a Working Capital to Net Assets ratio of -4.2% as of December 2025. Working capital of ₩-8.48 Billion (current assets of ₩95.18 Billion minus current liabilities of ₩103.66 Billion) is measured against net assets of ₩201.55 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See net asset quality index of CMG Pharmaceutical Co. Ltd to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
CMG Pharmaceutical Co. Ltd Working Capital to Net Assets (2014–2025)
This chart shows how CMG Pharmaceutical Co. Ltd's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2014 to 2025. As of December 2025, the ratio stands at -4.2%, reflecting working capital of ₩-8.48 Billion against net assets of ₩201.55 Billion KRW. Check how tangible is CMG Pharmaceutical Co. Ltd's equity to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for CMG Pharmaceutical Co. Ltd (2014–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for CMG Pharmaceutical Co. Ltd from 2014 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market cap of CMG Pharmaceutical Co. Ltd.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -4.2% | ₩-8.48 Billion | ₩201.55 Billion | ₩95.18 Billion | ₩103.66 Billion | ▼ -36.0 pp |
| 2024 | 31.8% | ₩60.21 Billion | ₩189.54 Billion | ₩134.86 Billion | ₩74.64 Billion | ▼ -16.2 pp |
| 2023 | 47.9% | ₩91.21 Billion | ₩190.23 Billion | ₩115.74 Billion | ₩24.53 Billion | ▼ -13.2 pp |
| 2022 | 61.2% | ₩113.17 Billion | ₩184.95 Billion | ₩135.07 Billion | ₩21.90 Billion | ▲ +0.7 pp |
| 2021 | 60.5% | ₩111.75 Billion | ₩184.70 Billion | ₩125.48 Billion | ₩13.73 Billion | ▼ -12.6 pp |
| 2020 | 73.1% | ₩132.33 Billion | ₩181.13 Billion | ₩145.98 Billion | ₩13.65 Billion | ▼ -5.4 pp |
| 2019 | 78.4% | ₩141.28 Billion | ₩180.16 Billion | ₩150.58 Billion | ₩9.31 Billion | ▲ +8.3 pp |
| 2018 | 70.1% | ₩72.88 Billion | ₩103.98 Billion | ₩81.37 Billion | ₩8.50 Billion | ▼ -1.7 pp |
| 2017 | 71.8% | ₩70.34 Billion | ₩97.94 Billion | ₩81.23 Billion | ₩10.88 Billion | ▲ +2.9 pp |
| 2016 | 68.9% | ₩69.64 Billion | ₩101.11 Billion | ₩78.77 Billion | ₩9.14 Billion | ▲ +31.7 pp |
| 2015 | 37.2% | ₩17.42 Billion | ₩46.81 Billion | ₩26.27 Billion | ₩8.85 Billion | ▼ -2.7 pp |
| 2014 | 40.0% | ₩19.58 Billion | ₩49.00 Billion | ₩28.30 Billion | ₩8.72 Billion | — |